Synthetic Biologics (SYN) Reports FY18 Loss of $4.06

Synthetic Biologics (NYSE: SYN) reported FY18 EPS of ($4.06), versus ($6.23) reported last year.

Cash and cash equivalents on December 31, 2018 were $28.9 million, an increase of $11.8 million from December 31, 2017.

For earnings history and earnings-related data on Synthetic Biologics (SYN) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Algorhythm Holdings (RIME) Tops Q2 EPS by 54c
• Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M